AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Balancing yield with tax efficiency in a bond ladder helps you capture higher after-tax income while managing interest-rate risk and withdrawals.
28,655 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
DeXe shows resilience as on-chain activity climbs and wallet growth accelerates amid a broader market downturn. Analy...
Criminal networks are steering toward AI gear as data centers race to meet demand, creating a new cargo-theft economy...
Meta quietly positions itself as the strongest mega-cap alternative this summer, leveraging ad momentum and a new AI ...
The FTC and 11 states reached a $100 million settlement with Walmart over alleged wage and tip-disclosure violations ...
With the Fed chair signaling a hawkish tilt, markets brace for higher-for-longer policy. History suggests the last ti...
Bitcoin steadies near the top of its range as regulatory momentum builds. XRP, Pi Coin, and PEPE are flashing mixed s...
MicroStrategy moves forward with a bold plan to reach 1 million BTC by 2026, backed by a multi-billion-dollar financi...
PI tumbled again as conference buzz fades and the project presses ahead with roadmap milestones. Analysts frame it as...
A high-profile finale featuring Paul McCartney highlighted the financial calculus networks face as linear TV ad spend...
Dubai's property market is cooling as buyers pull back and prices fall. Analysts weigh whether the dip is a temporary...
A famous wall street futurist contends Starlink’s subscription revenue alone could underpin SpaceX’s multi-trillion-d...